据中国新闻网4月20日报道，综合日本媒体4月19日的最新消息，日本国立医药品食品卫生研究所在对小林制药公司一款含红曲成分的保健品原料进行检测时，发现除已知成分“软毛青霉酸”外，还存在至少两种未在产品说明中列出的“未预料到的物质”。
这一发现引发了公众对小林制药产品质量安全的关注。据了解，这些“未预料到的物质”的具体性质和可能对人体健康造成的影响尚未明确。日本国立医药品食品卫生研究所已对此事展开深入调查，以确定这些不明物质的成分、来源及潜在风险。
小林制药公司对此表示，他们正积极配合官方的调查，并对受影响的产品进行了主动召回，同时承诺将对内部生产流程进行全面审查，以确保产品质量和消费者的健康安全。
此次事件对小林制药的声誉造成了一定影响，该公司在国际市场上以生产高质量保健品而知名。目前，小林制药已承诺将尽快向公众公布调查结果，并采取必要的补救措施。
随着信息的进一步公开，消费者和业界对日本保健品监管体系的严谨性也提出了新的期待。此次事件也将促使相关部门加强对保健品市场的监管，以防止类似问题的再次发生。
英语如下：
**News Title:** “Japanese Media Expose Mystery Substance in KOKOBIAN Health Supplements: Safety Concerns Emerge”
**Keywords:** KOKOBIAN Pharmaceuticals, problematic health supplements, unexpected substances
**News Content:**
Title: Unforeseen Substances Found in KOKOBIAN Pharmaceutical Health Supplement Ingredients, Prompting Japanese Investigation
According to China News Agency on April 20, based on the latest reports from Japanese media on April 19, Japan’s National Institute of Health Sciences (NIHS) has discovered, during tests on a health supplement from KOKOBIAN Pharmaceutical containing red yeast rice, at least two unlisted “unexpected substances” in addition to the known component “monascin.”
This revelation has raised public concerns about the product safety of KOKOBIAN Pharmaceutical. The specific nature and potential health impacts of these “unexpected substances” remain unclear. The NIHS has launched a comprehensive investigation to identify the components, origin, and potential risks of these unknown materials.
In response, KOKOBIAN Pharmaceutical stated that they are cooperating fully with the authorities’ investigation, proactively recalling affected products, and pledged to conduct a thorough review of their internal production processes to ensure product quality and consumer health.
This incident has had a certain impact on the company’s reputation, which is renowned internationally for producing high-quality health supplements. KOKOBIAN Pharmaceutical has vowed to disclose the investigation results promptly and take necessary remedial actions.
As more information comes to light, consumers and the industry are now looking for stricter scrutiny of Japan’s health supplement regulatory system. This episode is expected to drive relevant authorities to strengthen the supervision of the health supplement market, preventing similar occurrences in the future.
【来源】http://www.chinanews.com/gj/2024/04-20/10202416.shtml
Views: 1